Cyclizine hydrochloride
CAS No. 303-25-3
Cyclizine hydrochloride( —— )
Catalog No. M18392 CAS No. 303-25-3
Cyclizine, sold under a number of brand names, is a medication used to treat and prevent nausea, vomiting and dizziness due to motion sickness or vertigo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 45 | In Stock |
|
| 200MG | 57 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCyclizine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclizine, sold under a number of brand names, is a medication used to treat and prevent nausea, vomiting and dizziness due to motion sickness or vertigo.
-
DescriptionCyclizine, sold under a number of brand names, is a medication used to treat and prevent nausea, vomiting and dizziness due to motion sickness or vertigo.(In Vitro):Cyclizine (100 μM) significantly inhibits nitrite accumulation and iNOS protein levels in the LPS-stimulated in RAW 264.7 cells supernatants.Cyclizine inhibits anti-IgE-induced histamine release from isolated human lung fragments, with an IC50 of 5.42 μM.(In Vivo):Cyclizine (1, 10 mg/kg) enhances locomotor activity of mice in a dose-dependent manner.
-
In VitroCyclizine (100 μM) hydrochloride significantly inhibits nitrite accumulation and iNOS protein levels in the LPS-stimulated in RAW 264.7 cells supernatants.Cyclizine hydrochloride inhibits anti-IgE-induced histamine release from isolated human lung fragments, with an IC50 of 5.42 μM.
-
In VivoCyclizine (1-10 mg/kg) hydrochloride enhances locomotor activity of mice in a dose-dependent manner.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetNeurokinin Receptor
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number303-25-3
-
Formula Weight302.85
-
Molecular FormulaC18H22N2·HCl
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN1CCN(CC1)C(c1ccccc1)c1ccccc1.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kuntzman, R., et al.: J. Pharmacol. Exp. Ther., 158, 332 (1967).
molnova catalog
related products
-
MLE-4901
A potent, selective, orally active neurokinin 3 (NK3R) antagonist for the treatment of schizophrenia.
-
Vofopitant
Vofopitant (GR 205171) is a potent NK1 receptor antagonist with anxiolytic and antiemetic activity for the study of post-traumatic stress disorder (PTSD).
-
SB-222200
SB-222200 is a selective, reversible, and competitive antagonist of the human NK-3 receptor(Ki=4.4 nM).
Cart
sales@molnova.com